Comparing Sodium Intake Strategies in Heart Failure: Rationale and Design of the Prevent Adverse Outcomes in Heart Failure by Limiting Sodium (PROHIBIT) Study

Circulation: Heart Failure

Volumn 8, Issue 3, 2015, Pages 636-645

  Butler, Javed ^a   Papadimitriou, Lampros ^a   Georgiopoulou, Vasiliki ^b   Skopicki, Hal ^a   Dunbar, Sandra ^b   Kalogeropoulos, Andreas ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

clinical trial; heart failure; outcomes assessment; sodium dietary

Indexed keywords

ADVERSE OUTCOME; ARTICLE; DIET SUPPLEMENTATION; DIETARY COMPLIANCE; FLUID INTAKE; FLUID RETENTION; FOLLOW UP; HEART FAILURE; HUMAN; HYPERVOLEMIA; PHASE 3 CLINICAL TRIAL (TOPIC); PILOT STUDY; PRIORITY JOURNAL; REGISTER; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SAFETY; SCREENING; SODIUM INTAKE; SODIUM RESTRICTION; WATER RETENTION; ADVERSE EFFECTS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DOUBLE BLIND PROCEDURE; METHODOLOGY; PATHOPHYSIOLOGY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME;

SODIUM INTAKE;

CLINICAL PROTOCOLS; DIET, SODIUM-RESTRICTED; DOUBLE-BLIND METHOD; HEART FAILURE; HUMANS; PILOT PROJECTS; REGISTRIES; RESEARCH DESIGN; RISK FACTORS; SODIUM, DIETARY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84942884427     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.114.001700     Document Type: Article

References (63)

1. Ghali JK, Kadakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intern Med. 1988;148:2013-2016.
2. Michalsen A, König G, Thimme W. Preventable causative factors leading to hospital admission with decompensated heart failure. Heart. 1998;80:437-441.
3. Tsuyuki RT, McKelvie RS, Arnold JM, Avezum A Jr, Barretto AC, Carvalho AC, Isaac DL, Kitching AD, Piegas LS, Teo KK, Yusuf S. Acute precipitants of congestive heart failure exacerbations. Arch Intern Med. 2001;161:2337-2342.
4. Dunbar SB, Clark PC, Reilly CM, Gary RA, Smith A, McCarty F, Higgins M, Grossniklaus D, Kaslow N, Frediani J, Dashiff C, Ryan R. A trial of family partnership and education interventions in heart failure. J Card Fail. 2013;19:829-841. doi: 10.1016/j.cardfail.2013.10.007.
5. Lennie TA, Song EK, Wu JR, Chung ML, Dunbar SB, Pressler SJ, Moser DK. Three gram sodium intake is associated with longer eventfree survival only in patients with advanced heart failure. J Card Fail. 2011;17:325-330. doi: 10.1016/j.cardfail.2010.11.008.
6. Malcom J, Arnold O, Howlett JG, Ducharme A, Ezekowitz JA, Gardner M, Giannetti N, Haddad H, Heckman GA, Isaac D, Jong P, Liu P, Mann E, McKelvie RS, Moe GW, Svendsen AM, Tsuyuki RT, O'Halloran K, Ross HJ, Sequeira EJ, White M; Canadian Cardiovascular Society. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure-2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. Can J Cardiol. 2008;24:21-40.
7. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119:1977-2016.
8. Royal College of Physicians. Chronic Heart Failure: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0046956/pdf/TOC.pdf. Accessed August 28, 2014.
9. Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Katz SD, Klapholz M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WHW, Teerlink JR, Walsh MN. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2010;16:e1-194.
10. McKelvie RS, Moe GW, Cheung A, Costigan J, Ducharme A, Estrella-Holder E, Ezekowitz JA, Floras J, Giannetti N, Grzeslo A, Harkness K, Heckman GA, Howlett JG, Kouz S, Leblanc K, Mann E, O'Meara E, Rajda M, Rao V, Simon J, Swiggum E, Zieroth S, Arnold JM, Ashton T, D'Astous M, Dorian P, Haddad H, Isaac DL, Leblanc MH, Liu P, Sussex B, Ross HJ. The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. Can J Cardiol. 2011;27:319-338. doi: 10.1016/j.cjca.2011.03.011.
11. Krum H, Jelinek MV, Stewart S, Sindone A, Atherton JJ; National Heart Foundation of Australia; Cardiac Society of Australia and New Zealand. 2011 update to National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006. Med J Aust. 2011;194:405-409.
12. McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GYH, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803-869.
13. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62:e147-e239. doi: 10.1016/j.jacc.2013.05.019.
14. Arcand JA, Brazel S, Joliffe C, Choleva M, Berkoff F, Allard JP, Newton GE. Education by a dietitian in patients with heart failure results in improved adherence with a sodium-restricted diet: a randomized trial. Am Heart J. 2005;150:716. doi: 10.1016/j.ahj.2005.02.016.
15. Chung ML, Moser DK, Lennie TA, Worrall-Carter L, Bentley B, Trupp R, Armentano DS. Gender differences in adherence to the sodium-restricted diet in patients with heart failure. J Card Fail. 2006;12:628-634. doi: 10.1016/j.cardfail.2006.07.007.
16. Kollipara UK, Mo V, Toto KH, Nelson LL, Schneider RA, Neily JB, Drazner MH. High-sodium food choices by southern, urban African Americans with heart failure. J Card Fail. 2006;12:144-148. doi: 10.1016/j.cardfail.2005.09.002.
17. Bashor TM, Granger CB, Hranitzky P, Patel MR. Current medical diagnosis & treatment. In: McPhee SJ, Papadakis MA, eds. Chapter 10. Heart Disease. New York, NY: The McGraw-Hill Companies, Inc; 2011.
18. Skorecki KL, Brenner BM. Body fluid homeostasis in congestive heart failure and cirrhosis with ascites. Am J Med. 1982;72:323-338.
19. Gupta D, Georgiopoulou VV, Kalogeropoulos AP, Dunbar SB, Reilly CM, Sands JM, Fonarow GC, Jessup M, Gheorghiade M, Yancy C, Butler J. Dietary sodium intake in heart failure. Circulation. 2012;126:479-485. doi: 10.1161/CIRCULATIONAHA.111.062430.
20. Volpe M, Tritto C, DeLuca N, Rubattu S, Rao MA, Lamenza F, Mirante A, Enea I, Rendina V, Mele AF. Abnormalities of sodium handling and of cardiovascular adaptations during high salt diet in patients with mild heart failure. Circulation. 1993;88(4 Pt 1):1620-1627.
21. McKie PM, Schirger JA, Costello-Boerrigter LC, Benike SL, Harstad LK, Bailey KR, Hodge DO, Redfield MM, Simari RD, Burnett JC Jr, Chen HH. Impaired natriuretic and renal endocrine response to acute volume expansion in pre-clinical systolic and diastolic dysfunction. J Am Coll Cardiol. 2011;58:2095-2103. doi: 10.1016/j.jacc.2011.07.042.
22. Masson S, Solomon S, Angelici L, Latini R, Anand IS, Prescott M, Maggioni AP, Tognoni G, Cohn JN; Val-Heft Investigators. Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT). J Card Fail. 2010;16:964-970. doi: 10.1016/j. cardfail.2010.06.417.
23. Mimran A, Guiod L, Hollenberg NK. The role of angiotensin in the cardiovascular and renal response to salt restriction. Kidney Int. 1974;5:348-355.
24. Cody RJ, Covit AB, Schaer GL, Laragh JH, Sealey JE, Feldschuh J. Sodium and water balance in chronic congestive heart failure. J Clin Invest. 1986;77:1441-1452. doi: 10.1172/JCI112456.
25. Damgaard M, Norsk P, Gustafsson F, Kanters JK, Christensen NJ, Bie P, Friberg L, Gadsbøll N. Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1294-R1301. doi: 10.1152/ajpregu.00738.2005.
26. Paterna S, Gaspare P, Fasullo S, Sarullo FM, Di Pasquale P. Normalsodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend Clin Sci (Lond). 2008;114:221-230. doi: 10.1042/CS20070193.
27. Paterna S, Parrinello G, Cannizzaro S, Fasullo S, Torres D, Sarullo FM, Di Pasquale P. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. Am J Cardiol. 2009;103:93-102. doi: 10.1016/j.amjcard.2008.08.043.
28. Parrinello G, Di Pasquale P, Licata G, Torres D, Giammanco M, Fasullo S, Mezzero M, Paterna S. Long-term effects of dietary sodium intake on cytokines and neurohormonal activation in patients with recently compensated congestive heart failure. J Card Fail. 2009;15:864-873. doi: 10.1016/j.cardfail.2009.06.002.
29. Nakasato M, Strunk CM, Guimarães G, Rezende MV, Bocchi EA. [Is the low-sodium diet actually indicated for all patients with stable heart failure]. Arq Bras Cardiol. 2010;94:92-101.
30. Verma S, Gupta M, Holmes DT, Xu L, Teoh H, Gupta S, Yusuf S, Lonn EM. Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study. Eur Heart J. 2011;32:2135-2142. doi: 10.1093/eurheartj/ehr066.
31. Arcand J, Ivanov J, Sasson A, Floras V, Al-Hesayen A, Azevedo ER, Mak S, Allard JP, Newton GE. A high-sodium diet is associated with acute decompensated heart failure in ambulatory heart failure patients: a prospective follow-up study. Am J Clin Nutr. 2011;93:332-337. doi: 10.3945/ajcn.110.000174.
32. Son YJ, Lee Y, Song EK. Adherence to a sodium-restricted diet is associated with lower symptom burden and longer cardiac event-free survival in patients with heart failure. J Clin Nurs. 2011;20:3029-3038. doi: 10.1111/j.1365-2702.2011.03755.x.
33. Song EK, Moser DK, Dunbar SB, Pressler SJ, Lennie TA. Dietary sodium restriction below 2 g per day predicted shorter event-free survival in patients with mild heart failure. Eur J Cardiovasc Nurs. 2014;13:541-548. doi: 10.1177/1474515113517574.
34. Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J. 2003;145:459-466. doi: 10.1067/mhj.2003.166.
35. Paterna S, Di Pasquale P, Parrinello G, Fornaciari E, Di Gaudio F, Fasullo S, Giammanco M, Sarullo FM, Licata G. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus highdose furosemide alone in refractory congestive heart failure: a doubleblind study. J Am Coll Cardiol. 2005;45:1997-2003. doi: 10.1016/j. jacc.2005.01.059.
36. Paterna S, Fasullo S, Parrinello G, Cannizzaro S, Basile I, Vitrano G, Terrazzino G, Maringhini G, Ganci F, Scalzo S, Sarullo FM, Cice G, Di Pasquale P. Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study). Am J Med. Sci. 2011;342:27-37. doi: 10.1097/MAJ.0b013e31820f10ad.
37. Hummel SL, Seymour EM, Brook RD, Sheth SS, Ghosh E, Zhu S, Weder AB, Kovács SJ, Kolias TJ. Low-sodium DASH diet improves diastolic function and ventricular-arterial coupling in hypertensive heart failure with preserved ejection fraction. Circ Heart Fail. 2013;6:1165-1171. doi: 10.1161/CIRCHEARTFAILURE.113.000481.
38. Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med. 1985;103:1-6.
39. Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensinconverting-enzyme inhibitors: the CHARM-Alternative trial. Lancet. 2003;362:772-776. doi: 10.1016/S0140-6736(03)14284-5.
40. Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010;376:875-885. doi: 10.1016/S0140-6736(10)61198-1.
41. Giamouzis G, Kalogeropoulos A, Georgiopoulou V, Laskar S, Smith AL, Dunbar S, Triposkiadis F, Butler J. Hospitalization epidemic in patients with heart failure: risk factors, risk prediction, knowledge gaps, and future directions. J Card Fail. 2011;17:54-75. doi: 10.1016/j. cardfail.2010.08.010.
42. Bernstein AM, Willett WC. Trends in 24-h urinary sodium excretion in the United States, 1957-2003: a systematic review. Am J Clin Nutr. 2010;92:1172-1180. doi: 10.3945/ajcn.2010.29367.
43. United States Department of Agriculture. Dietary Guidelines for Americans. http://www.cnpp.usda.gov/DGAs2010-PolicyDocument. htm. Accessed August 28, 2014.
44. Strom BL, Anderson CA, Ix JH. Sodium reduction in populations: insights from the Institute of Medicine committee. JAMA. 2013;310: 31-32. doi: 10.1001/jama.2013.7687.
45. Holst M, Strömberg A, Lindholm M, Willenheimer R. Description of selfreported fluid intake and its effects on body weight, symptoms, quality of life and physical capacity in patients with stable chronic heart failure. J Clin Nurs. 2008;17:2318-2326. doi: 10.1111/j.1365-2702.2008.02295.x.
46. Travers B, O'Loughlin C, Murphy NF, Ryder M, Conlon C, Ledwidge M, McDonald K. Fluid restriction in the management of decompensated heart failure: no impact on time to clinical stability. J Card Fail. 2007;13:128-132. doi: 10.1016/j.cardfail.2006.10.012.
47. Bentley B. A review of methods to measure dietary sodium intake. J Cardiovasc Nurs. 2006;21:63-67.
48. Arcand J, Floras JS, Azevedo E, Mak S, Newton GE, Allard JP. Evaluation of 2 methods for sodium intake assessment in cardiac patients with and without heart failure: the confounding effect of loop diuretics. Am J Clin Nutr. 2011;93:535-541. doi: 10.3945/ajcn.110.004457.
49. IOM. Dietary Reference Intakes (DRIs): Recommended Intakes for Individuals. http://www.nal.usda.gov/fnic/DRI/DRI-Tables/estimated-average-requirements.pdf. Accessed August 28, 2014.
50. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117-1124. doi: 10.1056/NEJM199704173361601.
51. Neaton JD, Grimm RH Jr, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, Cutler JA, Flack JM, Schoenberger JA, McDonald R. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA. 1993;270:713-724.
52. Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ. 2005;330:625. doi: 10.1136/bmj.330.7492.625.
53. Lerner A. New therapeutic strategies for celiac disease. Autoimmun Rev. 2010;9:144-147. doi: 10.1016/j.autrev.2009.05.002.
54. Makhanova N, Sequeira-Lopez ML, Gomez RA, Kim HS, Smithies O. Disturbed homeostasis in sodium-restricted mice heterozygous and homozygous for aldosterone synthase gene disruption. Hypertension. 2006;48:1151-1159. doi: 10.1161/01.HYP.0000249902.09036.e7.
55. Prakash MR, Norgren R. Comparing salt appetites: induction with intracranial hormones or dietary sodium restriction. Brain Res Bull. 1991;27:397-401.
56. Fitzsimons JT. Angiotensin, thirst, and sodium appetite. Physiol Rev. 1998;78:583-686.
57. Francis J, Weiss RM, Wei SG, Johnson AK, Beltz TG, Zimmerman K, Felder RB. Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am J Physiol Heart Circ Physiol. 2001;281:H2241-H2251.
58. Philipson H, Ekman I, Swedberg K, Schaufelberger M. A pilot study of salt and water restriction in patients with chronic heart failure. Scand Cardiovasc J. 2010;44:209-214. doi: 10.3109/14017431003698523.
59. Colín Ramírez E, Castillo Martínez L, Orea Tejeda A, Rebollar González V, Narvaéz David R, Asensio Lafuente E. Effects of a nutritional intervention on body composition, clinical status, and quality of life in patients with heart failure. Nutrition. 2004;20:890-895. doi: 10.1016/j. nut.2004.06.010.
60. Volpe M, Magri P, Rao MA, Cangianiello S, DeNicola L, Mele AF, Memoli B, Enea I, Rubattu S, Gigante B, Trimarco B, Epstein M, Condorelli M. Intrarenal determinants of sodium retention in mild heart failure: effects of angiotensin-converting enzyme inhibition. Hypertension. 1997;30(2 Pt 1):168-176.
61. Alvelos M, Ferreira A, Bettencourt P, Serraõ P, Pestana M, Cerqueira-Gomes M, Soares-Da-Silva P. The effect of dietary sodium restriction on neurohumoral activity and renal dopaminergic response in patients with heart failure. Eur J Heart Fail. 2004;6:593-599. doi: 10.1016/j. ejheart.2003.11.020.
62. Luft FC, Sloan RS, Fineberg NS, Free AH. The utility of overnight urine collections in assessing compliance with a low sodium intake diet. JAMA. 1983;249:1764-1768.
63. Luft FC, Fineberg NS, Sloan RS. Estimating dietary sodium intake in individuals receiving a randomly fluctuating intake. Hypertension. 1982;4:805-808.